ÎÚÑ»´«Ã½

Following a recent high-profile death, ketamine—for decades used as a popular party drug—came under public scrutiny for its use as a treatment for everything from psychiatric illnesses to autoimmune diseases.

Unused or leftover prescription medications can be dangerous—even lethal. So why are so many Americans hanging onto them?

Those calling for added oversight on alcohol are often cast as buzzkills; few seem to recognize drinking as the public health threat it is.  There are signs of a shift ahead, though, as interest rises in dry January and the popularity of nonalcoholic cocktails and near-beers continues to increase.

Methadone is proven to reduce the likelihood of dying from an overdose by 50% or more. Why is it so hard to get?

Science is trying to catch up as states legalize cannabis, social norms evolve, and an already intricate market of medical and recreational products charges forward.

An animal tranquilizer is turning up in illicit opioid supplies, raising the risk of harm and death.

Narcan, the naloxone nasal spray used to reverse opioid overdose, was just FDA-approved for over-the-counter sale—a major victory for harm reduction advocates and public health. 

An accomplished biostatistician, Stuart collaborates across areas that include mental health, substance use, gun violence prevention, and education.

Rock County, WI, and the state of Colorado were recognized for their approach to opioid litigation settlements.

Court documents, including emails, reveal Insys Therapeutics promoted fentanyl-spray cancer painkiller for off-label uses

Experts from the School’s Bloomberg American Health Initiative provide 10 evidence-based recommendations to save lives

UCSF-Johns Hopkins Archive’s latest release of records illustrates pharmacies’ repeated failure to heed warning signs and safety guidelines.

Opioid industry documents illuminate the cynical strategies that led to thousands of deaths. Can an archive turn the tragic past into a better future?

The UCSF-JHU Opioid Industry Documents Archive released more than 114,000 documents related to McKinsey & Company's work showing how they advised opioid makers to help increase sales, despite the growing public outcry over the opioid epidemic.